Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Arno Therapeutics.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Arno Therapeutics
ClinicalTrials.gov Identifier:
NCT00956787
First received: August 7, 2009
Last updated: June 23, 2014
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)